Epithelial tissues form the body’s first line of defense, regulating barrier protection, tissue regeneration, and cellular signaling. Disruption of epithelial biology drives chronic inflammation, impaired healing, and disease progression across dermatology, ophthalmology, pulmonology, and urology. Understanding epithelial physiology is central to developing predictive in vitro systems and clinically relevant translational strategies.
Barrier defects contribute to skin disorders such as psoriasis and atopic dermatitis, while ocular surface disorders impair epithelial homeostasis and vision. In airway diseases including asthma and chronic bronchitis, epithelial signaling shapes inflammatory responses and environmental susceptibility. Urothelial alterations further drive urinary-tract dysfunction and urothelial cancers, highlighting the need for physiologically relevant epithelial models.
CELLnTEC advances epithelial research with precision cell culture systems, specialty media, and primary human epithelial cells optimized for robust 2D and 3D models. Our chemically defined, animal-component-free media generate reproducible, in vivo-like epithelial physiology across epidermis, oral, cornea, airway, and bladder systems, supporting both discovery research and translational workflows.
Our platforms support epithelial isolation, long-term expansion, stratification, barrier formation, and functional maturation under standardized conditions. These controlled culture systems enable reliable readouts of barrier integrity, differentiation state, inflammatory signaling, and tissue-like function for toxicology testing, disease modeling, and advanced screening platforms.
By improving reproducibility and scalability, our epithelial systems accelerate translational research, regenerative medicine, cell therapy, and ATMP development. Whether developing barrier-forming skin equivalents, corneal and airway models, bladder and oral epithelial systems, co-cultures, or organoids, CELLnTEC delivers clinically aligned platforms designed for clinical application development.
Precision-formulated epithelial media designed to mimic native in vivo microenvironments for each tissue type.
Supports tight junction formation and strong barrier function for reliable permeability assays.
Chemically defined, animal-component-free formulations that reduce experimental variability and regulatory complexity.
Supports antibiotic-free workflows where experimental sensitivity or regulatory frameworks require it.
Optimized for long-term culture, homeostasis, and aging studies in epithelial tissues.
Starter Kits and protocols for rapid 2D/3D model setup and onboarding of new users.
Pharmacokinetic and drug transport studies across epithelial barriers such as skin, cornea, airway, and bladder.
Cell–matrix interaction and extracellular matrix remodeling studies.
Wound healing, epithelial barrier integrity, and permeability assays.
Signal transduction, gene regulation, and stress responses.
Epithelial–stromal crosstalk with co-cultures
Alternative in vitro methods to replace or reduce animal testing in toxicity studies.
Host–pathogen interaction studies, including viral, bacterial, and fungal infections.
1
Universal base chemistry calibrated for epidermis, oral, corneal, airway, and bladder epithelia while preserving tissue-specific performance.
3
Formulations validated for monolayers, stratified epithelia, co-cultures, and complex 3D organotypic structures.
2
Formulation designed to support epithelial progenitors and maintain long-term growth potential in culture.
4
Engineered to generate consistent stratification, barrier formation, epithelial polarization, ciliation, or mucus production depending on tissue type.
Primary epithelial cells growing in CnT-NX-EX display a highly proliferative phenotype. For differentiation experiments, it is recommended to switch to the CnT-PR-D or CnT-PR-3D differentiation media.
